Abortion opponents urged the U.S. Supreme Court to allow new restrictions on a widely used pill to end pregnancy, presenting the justices with a stark choice on one of the country’s most divisive issues.
The Biden administration and Danco Laboratories LLC, the drug’s primary manufacturer, told the justices last week that lower court orders would create regulatory chaos and make it impossible to sell mifepristone legally in the near term. Unless the Supreme Court intervenes, the restrictions will take effect at the end of the day Wednesday.
In court filings Tuesday, anti-abortion groups and doctors said the drug’s supporters were overstating the potential impact. The groups cast the issue as largely about mail distribution, which the Food and Drug Administration approved in 2021 but would be blocked under last week’s ruling by the 5th U.S. Circuit Court of Appeals.
